Exercising greater process control and delivering improved yields are constant challenges for bioprocessing operations. Here’s how mass flow controllers help. Joe Sipka, Brooks Instrument The mass flow controller (MFC) is commonly used in many bioprocessing systems to manage the flow of different gases into bioreactor chambers. Intelligent MFC technology with digital-based flow-control capabilities can help…
ACG Group introduces next-gen pharma production, inspection and packaging equipment
ACG Group (Mumbai) this week rolled out what it described as a comprehensive portfolio of pharmaceutical production, inspection and packaging equipment. The portfolio draws on equipment technology from two of the company’s four business units: ACG Engineering and ACG Inspection. The machines — ranging from tablet presses to blister and carton packing equipment to serialization…
Pfizer to Buy Array Biopharma in Deal Worth $11.4B
Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array, whose product portfolio includes a treatment combination used…
Psoriasis Treatment Market to Gain $121 Billion by 2024
As reported by TMR, the global psoriasis treatment market is prognosticated to exhibit a 5.10 percent CAGR over the forecast period from 2016 to 2024. The market was estimated to be worth $7.8 bn in 2015 and is forecasted to reach $12.1 bn by 2024. North America is predicted to emerge as the leading region…
ADHD Drugs Market Will Register a CAGR of Almost 6 Percent by 2023
The rising incidence rate of ADHD among children is one of the critical factors that will trigger the growth of the attention deficit hyperactivity disorder drugs market. The expansion of the patient pool with positive ADHD symptoms is fueling the demand for ADHD therapies. As per the CDC, in 2016. Approximately 9.4 percent of children…
FDA Approves First Chemotherapy Regimen for Relapsed Diffuse Large B-cell Lymphoma
Computational Biology Market Size Worth $13.6 Billion by 2026
Antifreeze Proteins Market Will Register a CAGR of Over 30 Percent by 2023
Impending Patent Cliff Threatens Billions of Global Prescription Drug Sales
Over $198 billion in global prescription drug sales are at risk between 2019-2024 from patent expirations, according to a new report from EvaluatePharma. Experts are now warning that the pharmaceutical industry is on the brink of a second patent cliff. Worldwide prescription drug sales are expected to grow at a CAGR of 6.9 percent to $842…
FDA Approves First Treatment for Episodic Cluster Headache
The U.S. Food and Drug Administration approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults. “Emgality provides patients with the first FDA-approved drug that reduces the frequency of attacks of episodic cluster headache, an extremely painful and often debilitating condition,” said Eric Bastings, M.D., deputy director of the Division…